Загрузка...
ABHD6: its place in endocannabinoid signaling and beyond.
The endocannabinoid (eCB) signaling system modulates neurotransmission and inflammation, amongst other physiological functions. Its newest member, α/β-hydrolase domain containing 6 (ABHD6), has emerged as a promising therapeutic target to treat several devastating diseases, including epilepsy. We re...
Сохранить в:
| Опубликовано в: : | Trends Pharmacol Sci |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445269/ https://ncbi.nlm.nih.gov/pubmed/30853109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2019.02.002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|